Scarica l'app Stockscreener
1.50
4.46%
-0.07
Dopo l'orario di chiusura:
1.51
0.01
+0.67%
Precedente Chiudi:
$1.57
Aprire:
$1.57
Volume 24 ore:
1.03M
Relative Volume:
0.21
Capitalizzazione di mercato:
$4.93M
Reddito:
$12.99M
Utile/perdita netta:
$-23.72M
Rapporto P/E:
-0.0154
EPS:
-97.2514
Flusso di cassa netto:
$-23.28M
1 W Prestazione:
-14.77%
1M Prestazione:
+0.00%
6M Prestazione:
-91.61%
1 anno Prestazione:
-98.69%
Intervallo 1D:
$1.50
$1.585
Intervallo di 1 settimana:
$1.50
$1.7299
Portata 52W:
$1.32
$381.10
Aptevo Therapeutics Inc Stock (APVO) Company Profile
Nome
Aptevo Therapeutics Inc
Settore
Industria
Telefono
206-838-0500
Indirizzo
2401 4TH AVE., SEATTLE, WA
Confronta APVO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
APVO
Aptevo Therapeutics Inc
|
1.50 | 22.51M | 12.99M | -23.72M | -23.28M | -97.25 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Aptevo Therapeutics Inc Stock (APVO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2018-11-05 | Iniziato | Ladenburg Thalmann | Buy |
| 2017-10-05 | Ripresa | Piper Jaffray | Overweight |
Aptevo Therapeutics Inc Borsa (APVO) Ultime notizie
Aptevo Therapeutics Inc. (APVO) Stock Price | Live Quotes & Charts | NSC - StocksToTrade
Tools to assess Aptevo Therapeutics Inc.’s risk profileJuly 2025 Rallies & Comprehensive Market Scan Reports - newser.com
Order flow analysis tools used on Aptevo Therapeutics Inc.July 2025 Closing Moves & Short-Term Trading Alerts - newser.com
Why Aptevo Therapeutics Inc. stock appeals to analystsJuly 2025 News Drivers & Accurate Entry and Exit Point Alerts - newser.com
Why Aptevo Therapeutics Inc. stock remains on watchlistsWeekly Trend Report & AI Driven Stock Price Forecasts - newser.com
Will Aptevo Therapeutics Inc. stock recover faster than marketPortfolio Return Summary & Safe Entry Zone Identification - newser.com
Why Aptevo Therapeutics Inc. stock remains a top recommendationJuly 2025 Review & Risk Controlled Swing Trade Alerts - newser.com
Advanced analytics toolkit walkthrough for Aptevo Therapeutics Inc.July 2025 Price Swings & High Accuracy Buy Signal Tips - newser.com
Aptevo Therapeutics Expands Anti-Cancer Pipeline with Patents - MSN
Using portfolio simulators with Aptevo Therapeutics Inc. includedEarnings Performance Report & Weekly Stock Performance Updates - newser.com
Top chart patterns to watch in Aptevo Therapeutics Inc.2025 EndofYear Setup & Growth Focused Stock Pick Reports - newser.com
How sustainable is Aptevo Therapeutics Inc. stock dividend payoutJuly 2025 Volume & Free Community Supported Trade Ideas - newser.com
How to forecast Aptevo Therapeutics Inc. trends using time seriesJuly 2025 Analyst Calls & Community Trade Idea Sharing Platform - newser.com
Does Aptevo Therapeutics Inc. show high probability of reboundWeekly Market Report & Low Volatility Stock Recommendations - newser.com
Is Aptevo Therapeutics Inc. (AP81) stock inflation resilientWeekly Investment Report & Low Drawdown Momentum Ideas - newser.com
Relative strength of Aptevo Therapeutics Inc. in sector analysisChart Signals & Stock Timing and Entry Methods - newser.com
What’s the recovery path for long term holders of Aptevo Therapeutics Inc.July 2025 Update & Consistent Return Strategy Ideas - newser.com
Will Aptevo Therapeutics Inc. stock outperform international peers2025 Top Gainers & High Win Rate Trade Tips - newser.com
Why analysts raise outlook for Aptevo Therapeutics Inc. (AP81) stockJuly 2025 WrapUp & Weekly Setup with ROI Potential - newser.com
What MACD signals say about Aptevo Therapeutics Inc.July 2025 Short Interest & Low Risk Growth Stock Ideas - newser.com
Aptevo Presenting Scientific and Clinical Updates at SITC and ASH, also Participating in Leading Financial and Industry Conferences in the Fourth Quarter - ACCESS Newswire
Aptevo Presenting Scientific and Clinical Updates at SITC and ASH, Also Participating in Leading Financial and Industry Conferences in the Fourth Quarter - 富途牛牛
Interim RAINIER results: Aptevo to present Phase 1b/2 AML data at ASH, SITC, BIO-Europe and ROTH this fall - Stock Titan
APVO Stock Soars After Impressive Trial Results - StocksToTrade
APVO Stock Skyrockets: What’s Fueling the Growth? - timothysykes.com
Why Telomir Pharmaceuticals Shares Are Trading Higher By 31%; Here Are 20 Stocks Moving Premarket - Benzinga
Aptevo Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:APVO - Benzinga
Aptevo Therapeutics Inc Azioni (APVO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.96%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):